Halozyme Therapeutics Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2011 | 17.53x | $0.54 | $9.51 |
| Dec 2012 | 17.87x | $0.38 | $6.71 |
| Dec 2013 | 31.33x | $0.48 | $14.99 |
| Dec 2014 | 16.10x | $0.60 | $9.65 |
| Dec 2015 | 15.27x | $1.13 | $17.33 |
| Dec 2016 | 8.71x | $1.13 | $9.88 |
| Dec 2017 | 9.32x | $2.17 | $20.26 |
| Dec 2018 | 13.89x | $1.05 | $14.63 |
| Dec 2019 | 12.76x | $1.39 | $17.73 |
| Dec 2020 | 23.16x | $1.84 | $42.71 |
| Dec 2021 | 13.31x | $3.02 | $40.21 |
| Dec 2022 | 12.12x | $4.69 | $56.90 |
| Dec 2023 | 5.98x | $6.18 | $36.96 |
| Dec 2024 | 6.09x | $7.84 | $47.81 |
| Dec 2025 | 6.01x | $11.27 | $67.70 |